D. Herold

Age-related prostate cancer metastases.

A. Hanlon, B. Movsas, G. Hanks, 1998, Urology.

Postradiotherapy PSA nadirs fail to support dose escalation study in patients with pretreatment PSA values < 10 ng/ml.

A. Hanlon, B. Movsas, G. Hanks, 1997, Radiation oncology investigations.

Patient-Reported Quality of Life Outcomes in Intermediate-Risk Prostate Cancer Patients Treated With Stereotactic Body Radiation Therapy

I. Kaplan, C. Cotrutz, M. Sanda, 2013 .

Stereotactic Body Radiation Therapy for Intermediate-risk Organ-confined Prostate Cancer: Interim Toxicity and Quality of Life Outcomes From a Multi-institutional Study

I. Kaplan, C. Cotrutz, M. Sanda, 2012 .

Gold microspheres: a selective technique for producing biologically effective dose enhancement.

I J Das, I. Das, C. Stobbe, 2000, International journal of radiation biology.

Diabetes mellitus: a predictor for late radiation morbidity.

A. Hanlon, G. Hanks, D. Herold, 1999, International journal of radiation oncology, biology, physics.